Advertisement
Research Article Free access | 10.1172/JCI113485
Department of Medicine, University of California San Diego School of Medicine, La Jolla 92093.
Find articles by Garvey, W. in: JCI | PubMed | Google Scholar
Department of Medicine, University of California San Diego School of Medicine, La Jolla 92093.
Find articles by Huecksteadt, T. in: JCI | PubMed | Google Scholar
Department of Medicine, University of California San Diego School of Medicine, La Jolla 92093.
Find articles by Matthaei, S. in: JCI | PubMed | Google Scholar
Department of Medicine, University of California San Diego School of Medicine, La Jolla 92093.
Find articles by Olefsky, J. in: JCI | PubMed | Google Scholar
Published May 1, 1988 - More info
To examine the role of glucose transport proteins in cellular insulin resistance, we studied subcutaneous adipocytes isolated from lean control, obese control (body mass index [BMI] 33.4 +/- 0.9), and untreated obese non-insulin-dependent diabetes mellitus (NIDDM) patients (BMI 35.2 +/- 2.1; fasting glucose 269 +/- 20 mg/dl). Glucose transporters were measured in plasma membrane (PM), low-density (LDM), and high-density (HDM) microsomal subfractions from basal and maximally insulin-stimulated cells using the cytochalasin B binding assay, and normalized per milligram of membrane protein. In all subgroups, insulin led to an increase in PM glucose transporters and a corresponding depletion of transporters in the LDM. Insulin recruited 20% fewer transporters to the PM in the obese subgroup when compared with lean controls, and this was associated with a decline in LDM transporters with enlarging cell size in the control subjects. In NIDDM, PM, and LDM, transporters were decreased 50% in both basal and stimulated cells when compared with obese controls having similar mean adipocyte size. Cellular depletion of glucose transporters was not the only cause of insulin resistance, because the decrease in rates of [14C]-D-glucose transport (basal and insulin-stimulated) was greater than could be explained by reduced numbers of PM transporters in both NIDDM and obesity. In HDM, the number of transporters was not influenced by insulin and was similar in all subgroups. We conclude that (a) in NIDDM and obesity, both reduced numbers and impaired activity of glucose transporters contribute to cellular insulin resistance, and (b) in NIDDM, more profound cellular insulin resistance is associated primarily with a further depletion of cellular transporters.